Silbert

Cassava Science | Run for Alzheimer | Breakout soon?

Long
Silbert Updated   
NASDAQ:SAVA   Cassava Sciences, Inc.
The price of SAVA is forming a triangle whereby this formation is about to end very soon. Everyone is waiting for the results of the phase IIb study which will be reported in the mid of 2020. So the question is when the stock is going to break out of the low volatility phase. The first target for the upper side is 11$ which might be reached before the publication of the phase IIb results.
Comment:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.